| 产品描述: | PM-43I is a potent STAT6 inhibitor and can reduce STAT6 phosphorylation level. PM-43I can be used in allergic lung disease, allergic rhinitis, chronic pulmonary obstructive disease and cancer research. |
| 体外研究: |
PM-43I (intranasal administration; 5 μg per mouse; every other day; 18 d) activity is restricted to the lung by intranasal administration[1]. |
| 体内研究: |
PM-43I (0.05-5 μM; 2 h) inhibits IL-4 stimulated phosphorylation of STAT6 in Beas-2B immortalized human airway cells. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.286 ml |
6.428 ml |
12.857 ml |
| 5 mM |
0.257 ml |
1.286 ml |
2.571 ml |
| 10 mM |
0.129 ml |
0.643 ml |
1.286 ml |
| 50 mM |
0.026 ml |
0.129 ml |
0.257 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |